Menu Search
Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Learn moreSubscribe now

Switzerland

SPI Large Company IndexLast 5 days
Last price16,726.89
SPI Medium Company IndexLast 5 days
Last price22,959.22
SPI Small Company IndexLast 5 days
Last price31,390.67
Swiss All-Share IndexLast 5 days
Last price776.06
SMILast 5 days
Last price12,529.58

Loading...

CHF overview

PairLatest rateToday's change1 year change
CHFGBP0.937
GBP		0.0008 / 0.09%--
CHFEUR1.08
EUR		0.0013 / 0.12%--
CHFUSD1.26
USD		0.0044 / 0.35%--
CHFJPY189.61
JPY		0.04 / 0.02%--
CHFAUD1.94
AUD		0.0116 / 0.60%--
CHFCAD1.77
CAD		0.0035 / 0.20%--
CHFCNY8.97
CNY		0.0219 / 0.24%--

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Switzerland in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the SMI with the highest percent gain over one day.
ListingLastChangeVolume
Wisekey International Holding AGWIHN:SWX16.04
CHF		+1.62
+11.23%		110.92k
Ht5 LtdHT5:SWX1.51
CHF		+0.13
+9.42%		246.00
Swatch Group AGUHR:SWX172.00
CHF		+12.80
+8.04%		385.29k
Swatch Group AGUHRN:SWX34.68
CHF		+2.56
+7.97%		335.33k
Compagnie Financiere Richemont SACFR:SWX160.55
CHF		+9.55
+6.32%		1.63m
Kuros Biosciences AGKURN:SWX31.50
CHF		+1.74
+5.85%		579.41k
Lem Holding SALEHN:SWX494.00
CHF		+22.50
+4.77%		4.33k
V-ZUG Holding AGVZUG:SWX47.90
CHF		+1.90
+4.13%		6.66k
Santhera Pharmaceuticals Holding AGSANN:SWX9.90
CHF		+0.32
+3.34%		77.34k
Logitech International SALOGN:SWX86.44
CHF		+2.60
+3.10%		868.04k
Data delayed at least 15 minutes, as of Oct 15 2025 16:31 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.